Related Experiment Videos
Machine Learning Based Prediction of Hospital Mortality in Post-Cardiotomy Cardiogenic Shock with Mechanical Support
Ahmad Mahajna1,2,3, Michal Kawczynski1,2, Silvia Mariani2,4
1Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Maastricht, The Netherlands.
ESC Heart Failure
|June 13, 2026
Summary
Machine learning models show moderate ability to predict in-hospital mortality for patients with post-cardiotomy cardiogenic shock on extracorporeal life support (ECMO). Key predictors include age, lactate, and pH, aiding clinical decision-making.
Area of Science:
- Cardiology
- Medical Informatics
- Artificial Intelligence
Background:
- Post-cardiotomy cardiogenic shock (PCCS) patients requiring extracorporeal life support (ECMO) have high mortality rates.
- Accurate prognostication is crucial for optimizing clinical decision-making and resource allocation in these critically ill patients.
Purpose of the Study:
- To develop and evaluate machine learning (ML) models for predicting in-hospital mortality in PCCS patients on ECMO.
- To identify key predictors of mortality to improve risk stratification and clinical management.
Main Methods:
- Utilized data from the Extracorporeal Life Support Organization (ELSO) registry (2010-2020) including 5,982 adult patients.
- Trained six ML algorithms (boosting, decision tree, k-NN, random forest, naïve Bayes, neural networks) on integrated and preprocessed data.
- Validated models using a 60% training, 20% validation, and 20% test set split.
Main Results:
- The boosting algorithm achieved the highest predictive performance (AUC = 0.759), followed by random forest (AUC = 0.688).
- Significant predictors of mortality included age, lactate levels during support, arterial pH, and BMI.
- ECMO duration was a less reliable predictor, and transplant outcome prediction was limited by class imbalance.
Conclusions:
- ML models offer moderate predictive capability for in-hospital mortality in PCCS patients on ECMO.
- The random forest model highlights the utility of readily available clinical variables for risk assessment.
- Further external validation and calibration are necessary before clinical implementation; models can serve as dynamic risk assessment tools during ECMO support.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...